Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Polycystic Ovary Syndrome 7Neoplasms 3Melanoma 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Ovarian Neoplasms 2Obesity 2Infertility 2Glioblastoma 2Endometrial Neoplasms 2Breast Neoplasms 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1TP53 Y220C Mutation 1Sarcoma, Ewing 1Sarcoma 1Prostate Cancer Recurrent 1Progression-Free Survival 1Preleukemia 1Posterior Fossa Ependymal Tumor 1Osteosarcoma 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms by Site 1Metabolic Diseases 1Medulloblastoma 1Leukoplakia, Oral 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Hyperandrogenism 1

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1Specimen Handling 1Peripheral Blood Stem Cell Transplantation 1Metformin 1Immunotherapy, Adoptive 1Granulocyte Colony-Stimulating Factor 1Genetic Counseling 1Filgrastim 1Exercise 1Emapalumab 1Cyclophosphamide 1Busulfan 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cytopenia × Metformin × Clear all
NCT04741945 2024-11-22

Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

Rigshospitalet, Denmark

Phase 2 Recruiting
40 enrolled
Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Refractory, with Excess of Blasts, Preleukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡